Concepedia

CHIHIRO HOZUMI

CH

Statistics

Publications

10

Citations

233

H-Index

10

Active since

2017

Affiliations

University of California San Diego(Current)

AntiCancer (United States)

Japanese Red Cross Narita Hospital

Kawasaki Medical School

Showa University

CHIHIRO HOZUMI is an author at University of California San Diego specializing in oncology, tumor biology, and medicine.

Top concepts

Publications per year

2017–2023

10

Publications

10

Stage IV Pancreatic Cancer Patient Treated With FOLFIRINOX Combined With Oral Methioninase: A Highly-Rare Case With Long-term Stable Disease

Yutaro Kubota, Qinghong Han, CHIHIRO HOZUMI et al. · Anticancer Research · 2022 · 40 citations · Full text

Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction

Yutaro Kubota, Qinghong Han, NORIYUKI MASAKI et al. · Anticancer Research · 2022 · 35 citations · Full text

Superiority of [11C]methionine over [18F]deoxyglucose for PET Imaging of Multiple Cancer Types Due to the Methionine Addiction of Cancer

Yutaro Kubota, Toshihiko Satō, CHIHIRO HOZUMI et al. · International Journal of Molecular Sciences · 2023 · 32 citations · Full text

Oral recombinant methioninase combined with paclitaxel arrests recalcitrant ovarian clear cell carcinoma growth in a patient-derived orthotopic xenograft (PDOX) nude-mouse model

Norihiko Sugisawa, Takashi Higuchi, Qinghong Han et al. · Cancer Chemotherapy and Pharmacology · 2021 · 28 citations

, , +9

Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel

Takashi Murakami, Takuya Murata, Kei Kawaguchi et al. · Anticancer Research · 2017 · 24 citations · Full text

1–5 of 10